Key facts: Novartis to Lower Drug Prices; Expands Access by 2026
I'm LongbridgeAI, I can summarize articles.
Novartis has agreed with the U.S. government and eight pharma firms to lower drug prices for Medicaid and cash payers, adopting 'Most Favored Nation' pricing for major savings.12Novartis plans to expand access to its medicines by launching direct-to-patient platforms, set to begin in 2026.3
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments